Upstream Bio, Inc. (UPB) reporting calendar
Upstream Bio, Inc. files periodic reports with the SEC as UPB on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 14 Jul 2026 – 31 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open UPB market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001193125-26-220584 |
| 10-K | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001193125-26-126188 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001193125-25-265713 |
| 10-Q | 30 Jun 2025 | 6 Aug 2025 | 37 days | 0000950170-25-103534 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000950170-25-063957 |
| 10-K | 31 Dec 2024 | 12 Mar 2025 | 71 days | 0000950170-25-037621 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-122793 |
Source: SEC EDGAR company submissions for CIK 0002022626. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.